SR-9009 (Stenabolic) Capsules

€ 34,95

SR-9009 capsules, also identified as Stenabolic, contain a formulated presentation of a synthetic Rev-ErbA research compound offered by Raw Lab Chems with seller-specified ≥98% purity. The material is intended exclusively for controlled in-vitro, chemical, and analytical research.

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SKU: CERT-S-13120 Category:
Description

SR-9009 (Stenabolic) Capsules

Product Overview

SR-9009 capsules, also identified as Stenabolic, provide a formulated presentation of a synthetic research compound associated with Rev-ErbA receptor investigation. The supplied information describes SR-9009 as a ligand used experimentally in studies concerning Rev-ErbAα and Rev-ErbAβ, circadian regulation, transcriptional signaling, and related molecular pathways.

Raw Lab Chems presents this material exclusively for controlled in-vitro, chemical, and analytical research. The supplied specification states ≥98% purity for the underlying research compound. This value is treated as a seller-provided specification rather than independently verified analytical data.

Scientific investigation surrounding SR-9009 includes research into Rev-Erb-mediated transcription and the relationship between molecular clock pathways and cellular metabolism. The supplied source specifically references core clock genes such as BMAL1 and CLOCK and discusses experimental observations concerning mitochondrial function, energy expenditure, and lipid metabolism.

These subjects establish research context only. They do not demonstrate therapeutic, metabolic, weight-management, endurance, athletic, or other personal-use benefits.

Chemical Identity & Classification

The supplied systematic chemical name for SR-9009 is ethyl 3-[[[(4-chlorophenyl)methyl][(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate.

The supplied molecular formula is C20H24ClN3O4S. The material is classified in the provided information as a Rev-ErbA agonist and is also commonly identified by the name Stenabolic.

The systematic name identifies several structural features, including chlorophenyl, nitrothiophene, pyrrolidine, carbamate, and tertiary amino functionality. These characteristics can be relevant to structural identification and analytical differentiation from other experimental Rev-Erb ligands.

No CAS number or molecular weight was provided in the supplied capsule-specific source. Those values are therefore not introduced as product specifications.

Researchers can consult PubChem when reviewing publicly available chemical-reference information, while ensuring that any selected record corresponds precisely to the compound and chemical form being investigated.

Chemical & Physical Characteristics

The supplied product is described as encapsulated powder intended for laboratory measurement. No verified capsule color, shell material, dimensions, excipient composition, fill appearance, particle characteristics, or other formulation-specific physical properties were provided.

The molecular formula C20H24ClN3O4S applies to the underlying SR-9009 compound rather than the complete capsule formulation. Any capsule shell or excipients would represent additional formulation components and should be considered separately during formulation-specific analytical work.

No quantitative solubility, melting point, density, hygroscopicity, or other detailed physicochemical measurements were supplied in this source. These characteristics are therefore not inferred from information concerning related compounds.

The supplied storage information specifies a cool, dry environment between 15°C and 25°C with protection from direct sunlight and moisture. No product-specific stability study or validated shelf-life dataset was supplied.

Purity & Analytical Verification

The supplied specification for SR-9009 capsules is ≥98% purity for the underlying research compound.

The source additionally states that HPLC analysis is used to assess chemical purity and formulation concentration. Mass spectrometry and proton NMR are described as methods used to verify structural characteristics, including the chlorophenyl and nitrothiophene components.

No batch-specific chromatogram, mass spectrum, NMR spectrum, Certificate of Analysis, or independent laboratory report was supplied with the provided information. The stated purity and testing information should therefore be treated as seller-supplied rather than independently verified.

HPLC, LC-MS/MS, GC-MS, NMR, and related analytical methods may be relevant to laboratory characterization when appropriately validated for the intended research objective. These techniques can support investigation of identity, composition, purity, impurities, and structural characteristics.

For formulated materials, compound purity and capsule homogeneity represent separate analytical characteristics. A purity specification for SR-9009 itself does not independently establish uniform distribution throughout every formulated unit.

Quality Control & Batch Integrity

The supplied information states that batches undergo HPLC analysis and that mass spectrometry and proton NMR are used for structural characterization. It also describes encapsulation technology intended to provide uniform distribution of the research material.

No underlying chromatograms, spectra, formulation-validation data, manufacturing records, or batch-specific analytical reports were supplied. These statements are therefore retained as source-provided quality information rather than independently established product characteristics.

Reliable research records can include compound identity, formulation type, supplier, lot or batch identifier, receipt date, storage history, analytical observations, and chain-of-custody information where applicable.

When formulation homogeneity is an important experimental variable, it should be established through appropriate batch documentation or validated laboratory analysis rather than inferred solely from the nominal formulation.

No additional claims concerning third-party certification, manufacturing standards, or lot-to-lot reproducibility are made without supporting documentation.

Safety, Handling & Laboratory Precautions

SR-9009 should be handled exclusively by appropriately trained personnel in a controlled laboratory environment. Suitable personal protective equipment, ventilation, containment, access controls, and waste-management procedures should be established through institutional risk assessment and applicable safety documentation.

The compound’s experimental relationship with Rev-Erb signaling should be considered when establishing laboratory controls. Molecular or cellular activity does not establish safety or suitability for human or veterinary exposure.

Researchers should consult an applicable Safety Data Sheet for the exact material and formulation when developing procedures concerning accidental exposure, spills, contamination, environmental release, waste collection, and disposal.

Research material should remain secured against unauthorized access and separated from food, beverages, children, pets, and non-research environments.

Packaging, Labeling & Storage

The supplied information describes high-barrier, moisture-resistant, and UV-protective packaging intended to maintain chemical stability during transportation. No packaging specification, validation report, or supporting technical documentation was supplied to independently confirm those characteristics.

Storage information specifies a cool, dry environment between 15°C and 25°C with protection from direct sunlight and moisture. These conditions are retained as supplied guidance rather than represented as independently validated Raw Lab Chems stability specifications.

Researchers should follow documentation applicable to the specific batch, relevant SDS guidance, and institutional chemical-storage requirements.

Because the product is a formulated capsule material, laboratory records should distinguish the complete formulation from isolated SR-9009 reference material. Storage history should also be documented when temperature, moisture, light exposure, or other environmental factors could affect analytical observations or formulation integrity.

Intended Research Use & Market Positioning

SR-9009 is relevant to laboratory investigation of Rev-ErbA signaling, receptor-mediated transcription, circadian molecular pathways, comparative ligand chemistry, and analytical method development. The supplied source also identifies investigation of BMAL1, CLOCK, mitochondrial biology, and cellular metabolic pathways as research contexts.

References to energy expenditure, lipid metabolism, circadian regulation, or mitochondrial function describe experimental research subjects rather than established product benefits. No claim is made that the material improves metabolism, body composition, physical performance, sleep, circadian health, or any other physiological outcome.

Researchers comparing related catalog materials can separately examine Raw Lab Chems GW-0742 Capsules and SR-9009 Powder (Stenabolic). These represent different compounds or product formats and should not be treated as chemically or analytically interchangeable.

The Raw Lab Chems SR-9009 Stenabolic Capsules research listing provides the catalog reference for the formulation described here.

No medical, therapeutic, diagnostic, veterinary, metabolic-enhancement, weight-management, bodybuilding, athletic-performance, recreational, or consumptive application is represented by this description.

Ordering, Availability & Fulfillment

Institutional procurement of SR-9009 capsules should begin with confirmation of the required formulation, chemical identity, analytical documentation, institutional authorization, and jurisdiction-specific requirements applicable to the proposed research.

The supplied source refers to standard laboratory counts but does not provide verified current inventory or package-count information. Availability should therefore not be inferred from this description.

The source also describes specialized protective packaging and discreet worldwide shipping. These statements are not presented as verified Raw Lab Chems fulfillment guarantees because supporting logistics documentation was not supplied.

No claims are made concerning current stock, package configurations, dispatch schedules, delivery times, shipping destinations, courier services, tracking, payment methods, customs processing, or geographic availability.

Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of the material are permitted and appropriately authorized.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

SR-9009 is presented as an experimental laboratory research compound. Regulatory treatment may differ according to jurisdiction, intended research activity, institutional policy, and applicable medicines, sporting, chemical-control, or research frameworks.

Researchers and institutions are responsible for determining and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.

A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “SR-9009 (Stenabolic) Capsules”
Shipping & Delivery